-
Innovation Ranking
NewInnovation Ranking – Quanta Computer Inc
Quanta Computer Inc (Quanta) is a computer hardware company that designs and manufactures notebook computers. The company’s product portfolio include computers, cameras, home base PC, cloud server products, and smart devices among others. Quanta provides data centers and storage systems. It also offers network services, technical services, datacenter, and cloud services. Quanta provides its products and services to communication, consumer electronics, and cloud computing areas. It operates assembly plants and after-sales service centers in Taiwan, California and Tennessee in the...
-
Innovation Ranking
NewInnovation Ranking – Quanta Services Inc
Quanta Services Inc (Quanta) is a provider of contracting services and infrastructure solutions. It designs, installs, upgrades, repairs and maintains infrastructure of electric power transmission and distribution networks, substation facilities, renewable energy facilities, pipeline transmission and distribution systems and facilities, and related infrastructure. The company also provides emergency restoration services, upgrade of electric power infrastructure; designs, installs and maintains renewable energy generation facilities including solar, wind and certain types of natural gas; and oil and gas pipeline protection, integrity testing,...
-
Company Insights
Innovation and Patenting activity of Quanta Computer Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Quanta Computer Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Quanta Services Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Quanta Services Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QTX-3034 in Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QTX-3034 in Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QTX-3034 in Lung Cancer Drug Details: QTX3034 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QTX-3034 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QTX-3034 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QTX-3034 in Colorectal Cancer Drug Details: QTX3034 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QTX-3034 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QTX-3034 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QTX-3034 in Pancreatic Cancer Drug Details: QTX3034 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QTX-3034 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QTX-3034 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QTX-3034 in Solid Tumor Drug Details: QTX3034 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QTX-3034 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QTX-3034 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QTX-3034 in Endometrial Cancer Drug Details: QTX3034 is under development for the...